½ÃÀ庸°í¼­
»óǰÄÚµå
1542578

¼¼°èÀÇ Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2024-2032³â)

Global Photopheresis Products Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 173 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2024-2032³â Á¶»ç ±â°£¿¡ CAGR 5.92%·Î 2023³â 3¾ï 6,254¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â ¾à 6¾ï 836¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

ü¿Ü Æ÷ÅäÆä·¹½Ã½º(ECP)¶ó°íµµ ºÒ¸®´Â Æ÷ÅäÆä·¹½Ã½º´Â ±â°è¸¦ ÅëÇØ Ç÷¾×À» Á¦°ÅÇÏ°í ¹éÇ÷±¸¸¦ ºÐ¸®ÇÏ´Â ÀÇ·á Ä¡·á¸¦ ¸»ÇÕ´Ï´Ù. ±× ÈÄ ÀÌ ¹éÇ÷±¸¿¡ 8-¸ÞÅå½Ã¼Ö¶ó·»À̶ó´Â ¾àÁ¦¸¦ Á¶»çÇß½À´Ï´Ù. ±×·± ´ÙÀ½ ȯÀÚ¿¡°Ô Ç÷¾×À» µÇµ¹¸®±â Àü¿¡ UVA Á¶»ç°¡ ¼öÇàµË´Ï´Ù. Æ÷ÅäÆä·¹½Ã½º´Â ½ÉÀå ÀÌ½Ä °ÅºÎ ¹ÝÀÀ, Æó ÀÌ½Ä °ÅºÎ ¹ÝÀÀ, ÇǺΠT ¼¼Æ÷ ¸²ÇÁÁ¾(CTCL), ¸¸¼º ÀÌ½ÄÆí ´ë ¼÷ÁÖ Áúȯ(GVHD) µî ¿©·¯ ½É°¢ÇÑ ÁúȯÀÇ Ä¡·á¿¡ ÀÌ¿ëµË´Ï´Ù. À̰ÍÀº Ç÷¾× ¿©°ú Ä¡·áÀÌ¸ç ½ÅüÀÇ ¸é¿ª ½Ã½ºÅÛ¿¡ ÀÛ¿ëÇÏ¿© Áúº´À» Ä¡·áÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÀÚ°¡¸é¿ª ÁúȯÀÇ À¯º´·ü Áõ°¡, Àå±â À̽ÄÀÇ Áõ·Ê ¼ö Áõ°¡°¡ Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¹ÙÀÌ·¯½º °¨¿°ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °Ç°­ °ü¸® ÀÎÇÁ¶ó¸¦ °­È­ÇÏ´Â µ¥ ¸¹Àº ±¹°¡ÀÇ Á¤ºÎ ±â°üÀÌ ÁÖ·ÂÇÏ°í ½ÃÀå ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. Æ÷ÅäÆä·¹½Ã½º ºÐ¾ßÀÇ ÁÖ¿ä ±â¾÷ °£ÀÇ ÆÄÆ®³Ê½ÊÀÌ ²÷ÀÓ¾øÀÌ È®´ëµÇ°í ÀÖ´Â °ÍÀº ¸î °¡Áö Áß¿äÇÏ°í ±Ø´ÜÀûÀÎ Á¶°ÇÀ» ÅëÇÑ ¸é¿ªÁ¶Àý¿¡ ´ëÇÑ Æ÷ÅäÆä·¹½Ã½ºÀÇ ¿µÇâ·Â ÀÌÇØ¸¦ Çâ»ó½ÃŰ´Â µ¥ ±â¿©Çϰí ÀÖÀ¸¸ç, Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶ÇÇÑ, ¼¼°è ³ëÀÎ Àα¸ Áõ°¡¿Í ±â¼úÀÇ Áøº¸´Â ¾ÕÀ¸·Î ¸î ³âµ¿¾È Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷¿¡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ âÃâ ÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Force ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼® ¹× ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. °Ô´Ù°¡, ÀÌ·¯ÇÑ ÅøÀº Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Æ÷ÅäÆä·¹½Ã½º Á¦Ç° »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±ÙÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ¼öÁØ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇϹǷΠÀü·«°¡´Â ÇâÈÄ ±âȸ¿¡¼­ °¢ Á¦Ç° ¹× ¼­ºñ½ºÀÇ Å¸°Ù °èÃþÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çüº°

  • ¿ÀÇ ECP ½Ã½ºÅÛ
  • Ŭ·ÎÁîµå ECP ½Ã½ºÅÛ

¿ëµµº°

  • ÇǺΠT¼¼Æ÷ ¸²ÇÁÁ¾
  • ÀÌ½ÄÆí ´ë¼÷ÁÖº´
  • À̽İźιÝÀÀ
  • ÀÚ±â¸é¿ªÁúȯ

ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • Àü¹® Ŭ¸®´Ð

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼­ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÁßÁ¡À» µÓ´Ï´Ù.

¿äûÀÌ ÀÖÀ¸½Ã¸é ÀúÈñ¿¡°Ô ¿¬¶ôÇϽʽÿÀ. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå Æ÷ÅäÆä·¹½Ã½º Á¦Ç°-»ê¾÷ ºÐ¼®

  • ¼Ò°³: ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ±¸¸ÅÀÚ ¸ñ·Ï
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ¼¼°è ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

  • °³¿ä : Á¦Ç° À¯Çüº°
  • °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : Á¦Ç° À¯Çüº°
  • ¿ÀÇ ECP ½Ã½ºÅÛ
  • Ŭ·ÎÁîµå ECP ½Ã½ºÅÛ

Á¦6Àå Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ¼¼°è ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : ¿ëµµº°
  • ÇǺΠT¼¼Æ÷ ¸²ÇÁÁ¾
  • ÀÌ½ÄÆí ´ë¼÷ÁÖº´
  • À̽İźιÝÀÀ
  • ÀÚ±â¸é¿ªÁúȯ

Á¦7Àå Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ¼¼°è ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÃÖÁ¾ »ç¿ëÀÚº° °³¿ä
  • ÃÖÁ¾ »ç¿ëÀÚº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð

Á¦8Àå Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼Ò°³
  • ºÏ¹ÌÀÇ ¸ÅÃ⠺м®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ìº°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • À¯·´ ºÎ¹®º°
    • À¯·´ ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ±¹°¡º° À϶÷
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ±â¾÷°æÀï ±¸µµ

  • Æ÷ÅäÆä·¹½Ã½º Á¦Ç° ½ÃÀåÀÇ °æÀï
  • ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇùÁ¤
  • ÇÕº´, Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Macopharma
  • Med Tech Solutions GmbH
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Terumo Corporation
  • Mallinckrodt Pharmaceuticals Others Among Others
JHS 24.09.20

The global demand for Photopheresis Products Market is presumed to reach the market size of nearly USD 608.36 Million by 2032 from USD 362.54 Million in 2023 with a CAGR of 5.92% under the study period 2024-2032.

Photopheresis, also called extracorporeal photopheresis (ECP), refers to a medical treatment that eliminates blood through a machine and separates white blood cells. Then, these white cells are exposed to a medication called 8-methoxy psoralen. It is followed by UVA irradiation before recurring the blood to the patient. Photopheresis is utilized to treat several serious medical conditions like heart transplant rejection, lung transplant rejection, Cutaneous T-cell lymphoma (CTCL), and Chronic graft versus host disease (GVHD). It is a blood-filtering treatment that works with the immune system of the body to treat disease.

MARKET DYNAMICS

The rising autoimmune disease prevalence, increasing numbers of cases of organ transplantation are the primary factor driving the photopheresis products market. There is the escalating focus of the government bodies of numerous countries on ramping up the healthcare infrastructure due to rising viral infections cases, thus augmented the high market demand. The constantly growing partnerships between major players in the area of photopheresis will be inclined to improve the understanding of the photopheresis influence on immune modulations through several vital and extreme conditions is adding a positive impact on the photopheresis products market's growth. Moreover, the growing geriatric population numbers across the globe and advancement in technology are likely to create lucrative growth opportunities for key players of the photopheresis products market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Photopheresis Products. The growth and trends of Photopheresis Products industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Photopheresis Products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Open ECP System
  • Closed ECP System

By Application

  • Cutaneous T-cell lymphoma
  • Graft versus host disease
  • Transplant rejections
  • Autoimmune diseases

By End-user

  • Hospitals
  • Specialty Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Photopheresis Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Photopheresis Products market include Macopharma, Med Tech Solutions GmbH, Haemonetics Corporation, Fresenius Kabi AG, Terumo Corporation, Mallinckrodt Pharmaceuticals Others Among Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PHOTOPHERESIS PRODUCTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHOTOPHERESIS PRODUCTS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Open ECP System Historic and Forecast Sales By Regions
  • 5.4. Closed ECP System Historic and Forecast Sales By Regions

6. GLOBAL PHOTOPHERESIS PRODUCTS MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Cutaneous T-cell lymphoma Historic and Forecast Sales By Regions
  • 6.4. Graft versus host disease Historic and Forecast Sales By Regions
  • 6.5. Transplant rejections Historic and Forecast Sales By Regions
  • 6.6. Autoimmune diseases Historic and Forecast Sales By Regions

7. GLOBAL PHOTOPHERESIS PRODUCTS MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Specialty Clinics Historic and Forecast Sales By Regions

8. GLOBAL PHOTOPHERESIS PRODUCTS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PHOTOPHERESIS PRODUCTS COMPANIES

  • 9.1. Photopheresis Products Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF PHOTOPHERESIS PRODUCTS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Macopharma
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Med Tech Solutions GmbH
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Haemonetics Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Fresenius Kabi AG
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Terumo Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Mallinckrodt Pharmaceuticals Others Among Others
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦